BC
XYL icon

Barrett & Company’s Xylem XYL Stock Holding History

Barrett & Company’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$470K Buy
3,973
+217
+6% +$25K 0.13% 102
2026
Q1 		$449K Sell
3,756
-88
-2% -$11.5K 0.15% 90
2025
Q4 		$523K Sell
3,844
-22
-0.6% -$3.16K 0.17% 84
2025
Q3 		$570K Sell
3,866
-617
-14% -$85.6K 0.2% 76
2025
Q2 		$580K Buy
4,483
+427
+11% +$51.7K 0.22% 73
2025
Q1 		$485K Sell
4,056
-68
-2% -$8.43K 0.21% 80
2024
Q4 		$478K Buy
4,124
+119
+3% +$15K 0.2% 79
2024
Q3 		$541K Sell
4,005
-339
-8% -$45.4K 0.23% 74
2024
Q2 		$589K Buy
4,344
+3
+0.1% +$408 0.27% 64
2024
Q1 		$561K Sell
4,341
-48
-1% -$5.8K 0.27% 65
2023
Q4 		$502K Buy
4,389
+3
+0.1% +$299 0.27% 72
2023
Q3 		$399K Buy
4,386
+3
+0.1% +$309 0.24% 82
2023
Q2 		$494K Buy
4,383
+7
+0.2% +$740 0.29% 69
2023
Q1 		$458K Buy
4,376
+9
+0.2% +$940 0.29% 73
2022
Q4 		$483K Hold
4,367
– – 0.32% 66
2022
Q3 		$483K Buy
+4,367
New +$397K 0.32% 66

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Barrett & Company's XYL Position: Q2 2026 in Review

Barrett & Company increased its Xylem (XYL) stake by 5.8% in Q2 2026, buying an estimated $25K and bringing the position to 3,973 shares worth $470K. The position accounts for 0.13% of the portfolio, ranked #102.

Barrett & Company first reported a position in XYL in Q3 2022 and has held it in 16 quarters since. The position peaked at $589K in Q2 2024. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Barrett & Company held 3,973 shares of Xylem worth $470K as of Q2 2026.
  • Barrett & Company bought 217 Xylem shares in Q2 2026, an estimated $25K.
  • Xylem made up 0.13% of Barrett & Company's portfolio in Q2 2026, its #102 holding.
  • Barrett & Company first reported a position in Xylem in Q3 2022 and has held it in 16 quarters since.
  • Barrett & Company's Xylem position peaked at $589K in Q2 2024.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.